La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Laboratorio Reig Jofre Croissance future
Future contrôle des critères 4/6
Laboratorio Reig Jofre devrait augmenter ses bénéfices et son chiffre d'affaires de 24.4% et de 8.2% par an respectivement. Le BPA devrait croître de de 22.8% par an. Le rendement des capitaux propres devrait être 6.9% dans 3 ans.
Informations clés
24.4%
Taux de croissance des bénéfices
22.8%
Taux de croissance du BPA
Pharmaceuticals croissance des bénéfices | 15.3% |
Taux de croissance des recettes | 8.2% |
Rendement futur des capitaux propres | 6.9% |
Couverture par les analystes | Low |
Dernière mise à jour | 30 Jul 2024 |
Mises à jour récentes de la croissance future
Recent updates
Calculating The Fair Value Of Laboratorio Reig Jofre, S.A. (BME:RJF)
Jun 22These 4 Measures Indicate That Laboratorio Reig Jofre (BME:RJF) Is Using Debt Extensively
Feb 02This Analyst Just Downgraded Their Laboratorio Reig Jofre, S.A. (BME:RJF) EPS Forecasts
Mar 07We Think Laboratorio Reig Jofre (BME:RJF) Is Taking Some Risk With Its Debt
Mar 07Laboratorio Reig Jofre (BME:RJF) Seems To Use Debt Quite Sensibly
May 17The Laboratorio Reig Jofre (BME:RJF) Share Price Has Gained 146%, So Why Not Pay It Some Attention?
Mar 07Is Laboratorio Reig Jofre (BME:RJF) Using Too Much Debt?
Jan 14Laboratorio Reig Jofre (BME:RJF) Shareholders Booked A 47% Gain In The Last Year
Dec 05Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 408 | 17 | 9 | 35 | 1 |
12/31/2025 | 379 | 15 | 6 | 31 | 1 |
12/31/2024 | 349 | 11 | 5 | 24 | 1 |
6/30/2024 | 334 | 9 | -3 | 16 | N/A |
3/31/2024 | 326 | 9 | N/A | N/A | N/A |
12/31/2023 | 318 | 9 | 6 | 19 | N/A |
9/30/2023 | 316 | 12 | N/A | N/A | N/A |
6/30/2023 | 298 | 10 | 6 | 18 | N/A |
3/31/2023 | 286 | 10 | N/A | N/A | N/A |
12/31/2022 | 274 | 8 | 5 | 16 | N/A |
9/30/2022 | 262 | 4 | N/A | N/A | N/A |
6/30/2022 | 256 | 5 | -6 | 5 | N/A |
3/31/2022 | 245 | 3 | N/A | N/A | N/A |
12/31/2021 | 240 | 5 | -5 | 14 | N/A |
9/30/2021 | 237 | 6 | N/A | N/A | N/A |
6/30/2021 | 234 | 5 | 9 | 22 | N/A |
3/31/2021 | 234 | 6 | N/A | N/A | N/A |
12/31/2020 | 234 | 6 | 7 | 19 | N/A |
9/30/2020 | 229 | 8 | N/A | N/A | N/A |
6/30/2020 | 229 | 6 | -15 | 14 | N/A |
3/31/2020 | 219 | 6 | N/A | N/A | N/A |
12/31/2019 | 206 | 5 | -19 | 12 | N/A |
9/30/2019 | 199 | 7 | N/A | N/A | N/A |
6/30/2019 | 188 | 9 | -10 | 16 | N/A |
3/31/2019 | 188 | 9 | N/A | N/A | N/A |
12/31/2018 | 185 | 9 | -6 | 15 | N/A |
9/30/2018 | 185 | 10 | N/A | N/A | N/A |
6/30/2018 | 179 | 9 | -4 | 14 | N/A |
3/31/2018 | 175 | 9 | N/A | N/A | N/A |
12/31/2017 | 172 | 9 | N/A | 21 | N/A |
9/30/2017 | 164 | 5 | N/A | N/A | N/A |
6/30/2017 | 164 | 7 | N/A | 8 | N/A |
3/31/2017 | 164 | 8 | N/A | N/A | N/A |
12/31/2016 | 161 | 8 | N/A | -1 | N/A |
9/30/2016 | 160 | 5 | N/A | N/A | N/A |
6/30/2016 | 159 | 5 | N/A | 8 | N/A |
3/31/2016 | 156 | 5 | N/A | N/A | N/A |
12/31/2015 | 157 | 9 | N/A | 13 | N/A |
12/31/2014 | 133 | 9 | N/A | -13 | N/A |
9/30/2014 | 122 | 9 | N/A | 12 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: RJF's forecast earnings growth (24.4% per year) is above the savings rate (1.7%).
Bénéfices vs marché: RJF's earnings (24.4% per year) are forecast to grow faster than the Spanish market (9.6% per year).
Croissance élevée des bénéfices: RJF's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: RJF's revenue (8.2% per year) is forecast to grow faster than the Spanish market (4.7% per year).
Croissance élevée des revenus: RJF's revenue (8.2% per year) is forecast to grow slower than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de RJF devrait être faible dans 3 ans ( 6.9 %).